Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA/ FR0013154002 /
DIM
29.05.2024 9:09:20
|
Изменение
-2.05
|
Объем сделки |
Бид9:09:20 |
Предложение9:09:20 |
Рыночная капитализация |
Дивидендная доходность |
Коэффициент Цена/Доход |
184.45EUR
|
-1.10%
|
4,572 Оборот: 847,149 |
184.40Величина цены спроса: 10 |
184.75Величина цены предложения: 56 |
17.19 млрдEUR |
0.37% |
55.51 |
Описание деятельности
Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.
Правление & Наблюдательный совет
Исполнительный директор |
Dr. Joachim Kreuzburg |
Правление |
Alexandra Gatzemeyer, Dr. René Fáber |
Наблюдательный совет |
Joachim Kreuzburg, René Fáber, Pascale Boissel, Susan Dexter, Romaine Fernandes, Anne-Marie Graffin, Lothar Kappich, Henri Riey |
Календарь компании
CW 29 | 19.07.2024
Interim Report 2nd Quarter/6 Months
|
CW 42 | 17.10.2024
Interim Report 3rd Quarter/9 Months
|